纤溶酶原激活物抑制剂1是纤维蛋白溶解系统的一个成分,许多研究发现血浆纤溶酶原激活物抑制剂1水平和基因多态性与静脉血栓栓塞性疾病的发生有显著的关系。
Plasminogen activator inhibitor-1 is a component in fibrinolysis system. It is reported that there is prominent relationship between plasma level, genetic polymorphism of plasminogen activator inhibitor-I and many venous thromboembolic diseases.